SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
7666099
Source:
http://linkedlifedata.com/resource/pubmed/id/7666099
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0019829
,
umls-concept:C0030705
,
umls-concept:C0038952
,
umls-concept:C0043432
,
umls-concept:C0087111
,
umls-concept:C0332325
pubmed:issue
9
pubmed:dateCreated
1995-10-6
pubmed:abstractText
A follow-up study was initiated of patients with Hodgkin's disease who were treated with yttrium 90-labeled antiferritin. Prescription method, pharmacokinetics, acute and late side effects, and survival were evaluated.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/P01 CA43791
,
http://linkedlifedata.com/resource/pubmed/grant/R01 CA51161
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies
,
http://linkedlifedata.com/resource/pubmed/chemical/Ferritins
,
http://linkedlifedata.com/resource/pubmed/chemical/Yttrium Radioisotopes
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0732-183X
pubmed:author
pubmed-author:HerpstJ MJM
,
pubmed-author:KleinJ LJL
,
pubmed-author:LeichnerP KPK
,
pubmed-author:QuadriS MSM
,
pubmed-author:VriesendorpH MHM
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2394-400
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:7666099-Adolescent
,
pubmed-meshheading:7666099-Adult
,
pubmed-meshheading:7666099-Antibodies
,
pubmed-meshheading:7666099-Bone Marrow Transplantation
,
pubmed-meshheading:7666099-Combined Modality Therapy
,
pubmed-meshheading:7666099-Drug Resistance
,
pubmed-meshheading:7666099-Female
,
pubmed-meshheading:7666099-Ferritins
,
pubmed-meshheading:7666099-Follow-Up Studies
,
pubmed-meshheading:7666099-Hodgkin Disease
,
pubmed-meshheading:7666099-Humans
,
pubmed-meshheading:7666099-Male
,
pubmed-meshheading:7666099-Middle Aged
,
pubmed-meshheading:7666099-Radioimmunotherapy
,
pubmed-meshheading:7666099-Remission Induction
,
pubmed-meshheading:7666099-Survival Rate
,
pubmed-meshheading:7666099-Transplantation, Autologous
,
pubmed-meshheading:7666099-Yttrium Radioisotopes
pubmed:year
1995
pubmed:articleTitle
Survival of patients with resistant Hodgkin's disease after polyclonal yttrium 90-labeled antiferritin treatment.
pubmed:affiliation
Division of Radiation Oncology, Johns Hopkins Hospital, Baltimore, MD, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, U.S. Gov't, Non-P.H.S.
,
Research Support, Non-U.S. Gov't